BILE ACID THERAPY FOR GALLSTONES
Ursodiol (ursodeoxycholic
acid) is a naturally occurring bile acidthat makes up less than 5% of the
circulating bile salt pool in humans and a much higher percentage in bears.
After oral admin-istration, it is absorbed, conjugated in the liver with
glycine or taurine, and excreted in the bile. Conjugated ursodiol undergoes
extensive enterohepatic recirculation. The serum half-life is approximately 100
hours. With long-term daily administration, ursodiol constitutes 30–50% of the
circulating bile acid pool. A small amount of unabsorbed conjugated or
unconjugated ursodiol passes into the colon, where it is either excreted or
undergoes dehydroxylation by colonic bacteria to lithocholic acid, a sub-stance
with potential hepatic toxicity.
The solubility of
cholesterol in bile is determined by the relative proportions of bile acids,
lecithin, and cholesterol. Although pro-longed ursodiol therapy expands the
bile acid pool, this does notappear to be the principal mechanism of action for
dissolution of gallstones. Ursodiol decreases the cholesterol content of bile
by reducing hepatic cholesterol secretion. Ursodiol also appears to stabilize
hepatocyte canalicular membranes, possibly through a reduction in the
concentration of other endogenous bile acids or through inhibition of
immune-mediated hepatocyte destruction.
Ursodiol
is used for dissolution of small cholesterol gallstones in patients with
symptomatic gallbladder disease who refuse chole-cystectomy or who are poor
surgical candidates. At a dosage of 10 mg/kg/d for 12–24 months, dissolution
occurs in up to 50% of patients with small (< 5–10 mm)
noncalcified gallstones. It is also effective for the prevention of gallstones
in obese patients undergoing rapid weight loss therapy. Several trials
demonstrate that ursodiol 13–15 mg/kg/d is helpful for patients with
early-stage primary biliary cirrhosis, reducing liver function abnormali-ties
and improving liver histology.
Ursodiol is
practically free of serious adverse effects. Bile salt-induced diarrhea is
uncommon. Unlike its predecessor, chenode-oxycholate, ursodiol has not been
associated with hepatotoxicity.
Related Topics
Privacy Policy, Terms and Conditions, DMCA Policy and Compliant
Copyright © 2018-2023 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.